Physician profile
Allison Clark
NPI 1750186581
$1,219.13
in general payments reported to CMS, 2019-2025
16 companies · $1,219 in 2025
The $1,219 reported for 2025 was more than what 88% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $1,219.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,191 · Consulting Fee: $27.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,191.14 |
| Consulting Fee | $27.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $289.58 | 2025 | |
| Astrazeneca Pharmaceuticals Lp | $192.73 | 2025 | Breztri, Tezspire, Airsupra |
| Ars Pharmaceuticals Operations, INC. | $177.93 | 2025 | Neffy |
| Blueprint Medicines Corporation | $93.35 | 2025 | Ayvakit |
| Gc Biopharma USA, INC. | $84.68 | 2025 | Alyglo |
| Takeda Pharmaceuticals U.S.A., INC. | $60.98 | 2025 | Cuvitru, Hyqvia |
| Regeneron Healthcare Solutions, INC. | $55.34 | 2025 | Dupixent |
| Glaxosmithkline, LLC. | $48.06 | 2025 | Trelegy Ellipta |
| Ionis Pharmaceuticals, INC. | $47.73 | 2025 | Dawnzera |
| Organon LLC | $37.94 | 2025 | |
| Csl Behring | $37.35 | 2025 | Hizentra, Andembry |
| Adma Biomanufacturing LLC | $27.99 | 2025 | |
| Amgen INC. | $17.87 | 2025 | Tezspire |
| Incyte Corporation | $16.93 | 2025 | Opzelura |
| Genzyme Corporation | $15.66 | 2025 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viatris Specialty LLC | $15.01 | 2025 | Yupelri |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allison Clark listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.